Track record · closed signal

XP Inc. (XP) — closed signal from August 27, 2025

Partial Published before the outcome was known, scored automatically when the window closed on November 25, 2025.

Predicted vs. what happened

XP price · publication thesis → realized outcomesplit-adjusted
$16.70 Published $20.99 Target $17.97 Window close $20.15 Peak
$16.17 – $16.66Entry zone — fair-value band
$16.70Published — price the day we called it
$20.99Target — the price the thesis aimed for
$20.15Peak — highest point inside the window, not a realized return
$17.97Window close — end-of-window price, context only

What happened

Partial

Reached 77% of the predicted growth at its peak, without hitting the target.

Peak price
$20.15
peak on September 17, 2025 — not a realized return
Peak gain
+20.7%
peak, from the publication price
Window close
$17.97
end-of-window price, context only
Days to target
Window
August 27, 2025 – November 25, 2025

The thesis — published August 27, 2025

Predicted growth
+27%
over the measurement window
Target price
$20.99
the price the thesis aimed for
Entry zone
$16.17 – $16.66
the fair-value band we waited for
Price at publication
$16.70
published August 27, 2025
Confidence
74%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

XP looks like a value-friendly idea with a price trying to work higher. Recent quarterly results showed profit per share was solid even though sales lagged (2025-08-20). Zacks gave it their top rank and an A for value (2025-08-25). Trading action suggests growing buyer interest, and short interest near 7% (2025-08-20) adds risk but could boost gains. Buying around $16.50-$17.00 aims for prior highs within 0-3 months.

Primary drivers

  • Profit per share beat views even though sales trailed
  • Top value rating from Zacks on 2025-08-25
  • Buying interest looks stronger than selling lately
  • Many are betting against it; rising prices could force buys

How it played out

XP: the thesis partly played out but missed the target

Lyra published XP at $16.70 on 2025-08-27 with expected growth of 27%. The thesis pointed to a profit per share beat even though sales trailed, a top value rating from Zacks on 2025-08-25, stronger buying interest than selling, and short interest near 7% as a risk that could also support gains.

Inside the 2025-08-27 to 2025-11-25 window, XP rose to a peak of $20.15 on 2025-09-17. That was a 20.7% gain, but it stayed below the $20.99 target. It ended at $17.97. The call partly worked, but the target was not reached.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.